Insulet | PODD - Marktkapitalisierung

Aktienkurs
189.99
Täglich Wechseln
0.43 0.23%
Monatlich
-12.04%
Jährlich
-27.13%
Q2 Prognose
185.50




Marktkapitalisierung Veränderung Datum
Abbott USD 168.02B 10.39B 2026-04
Align Technology USD 11.2B 2.13B 2025-12
AtriCure USD 1.97B 215M 2025-12
Avanos Medical USD 521M 15M 2025-12
Baxter International USD 9.82B 1.87B 2025-12
Becton, Dickinson and Co. USD 55.29B 1.64B 2025-12
Boston Scientific USD 95.61B 2.35B 2026-04
Cardinal Health USD 48.83B 11.54B 2025-12
Cooper Companies USD 15.95B 2.05B 2025-12
Dexcom USD 25.88B 503M 2025-12
Edwards Lifesciences USD 47.05B 884M 2026-04
Eli Lilly USD 1.02T 293.84B 2025-12
Globus Medical USD 11.69B 3.95B 2025-12
ICU Medical USD 3.52B 561M 2025-12
Insulet USD 20B 1.74B 2025-12
Integra LifeSciences USD 967M 150M 2025-12
J&J USD 561.65B 17.5B 2026-04
Masimo USD 6.84B 839M 2025-12
Merit Medical Systems USD 5.23B 297M 2025-12
Roche Holding CHF 266.34B 55.46B 2025-12
Stryker USD 134.41B 6.92B 2025-12
Tandem Diabetes Care USD 1.49B 670M 2025-12
Teleflex USD 5.39B 91M 2025-12
West Pharmaceutical Services USD 22.67B 4.61B 2026-04
WK Kellogg Co USD 13.74B 1.09B 2025-12
Zimmer Biomet Holdings USD 17.82B 1.69B 2025-12